{"title":"The value of handheld ultrasound in point-of-care or at home EF prediction.","authors":"Yue Jiang, Lingyan Zhang, Zhaoyang Liu, Lei Wang","doi":"10.1080/00015385.2025.2490382","DOIUrl":null,"url":null,"abstract":"<p><p>In this paper, AI-enabled handheld ultrasound is used in point-of-care or at home, and evaluate the accuracy of it for left ventricular ejection fraction (LVEF) evaluation. It provides a simple, convenient, and practical tool for the patients with heart disease, especially those with heart failure. The AI model used for this AI-enabled handheld ultrasound is a machine learning model trained with tens of thousands of ultrasound four-chamber cardiograms. The LVEF evaluation accuracy of the AI model was compared by the experts performing ultrasound four-chamber cardiogram detection in 100 patients on high-end ultrasound in the hospital. In the 100 clinical trials, the sensitivity, specificity, and accuracy of the AI model were 91%, 95%, and 98%, respectively. Then 10 cases were used to compare the LVEF results of hospital tests with the predicted results of the AI model. The difference between the two is less than 10%. Finally, over the course of one month, the AI-enabled handheld ultrasound was employed to conduct regular evaluations of left LVEF for point-of-care purposes on a group of 10 patients diagnosed with heart failure. The LVEF evaluation accuracy of AI-enabled handheld ultrasound is more than 96%, which was higher than that of experts in high-end ultrasound in hospitals. The easy-to-use AI-enabled handheld ultrasound can evaluate the LVEF in the point of care or at home and get the same accuracy as the high-end ultrasound equipment in the hospital. It may play an important role in monitoring cardiac function at home for the ambulatory heart failure patients.</p>","PeriodicalId":6979,"journal":{"name":"Acta cardiologica","volume":" ","pages":"1-7"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta cardiologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00015385.2025.2490382","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
In this paper, AI-enabled handheld ultrasound is used in point-of-care or at home, and evaluate the accuracy of it for left ventricular ejection fraction (LVEF) evaluation. It provides a simple, convenient, and practical tool for the patients with heart disease, especially those with heart failure. The AI model used for this AI-enabled handheld ultrasound is a machine learning model trained with tens of thousands of ultrasound four-chamber cardiograms. The LVEF evaluation accuracy of the AI model was compared by the experts performing ultrasound four-chamber cardiogram detection in 100 patients on high-end ultrasound in the hospital. In the 100 clinical trials, the sensitivity, specificity, and accuracy of the AI model were 91%, 95%, and 98%, respectively. Then 10 cases were used to compare the LVEF results of hospital tests with the predicted results of the AI model. The difference between the two is less than 10%. Finally, over the course of one month, the AI-enabled handheld ultrasound was employed to conduct regular evaluations of left LVEF for point-of-care purposes on a group of 10 patients diagnosed with heart failure. The LVEF evaluation accuracy of AI-enabled handheld ultrasound is more than 96%, which was higher than that of experts in high-end ultrasound in hospitals. The easy-to-use AI-enabled handheld ultrasound can evaluate the LVEF in the point of care or at home and get the same accuracy as the high-end ultrasound equipment in the hospital. It may play an important role in monitoring cardiac function at home for the ambulatory heart failure patients.
期刊介绍:
Acta Cardiologica is an international journal. It publishes bi-monthly original, peer-reviewed articles on all aspects of cardiovascular disease including observational studies, clinical trials, experimental investigations with clear clinical relevance and tutorials.